Table of Contents
Table 5-19: Dubois
Table 5-21: Fayette
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2000 | 1996 - 2000 | 2000 | 1996 - 2000 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 311 | 445.5 | 1,445 | 417.8 | 163 | 243.8 | 797 | 243.5 |
| Esophagus | 6 | 9.4** | 29 | 8.1 | 6 | 8.0** | 25 | 7.0 |
| Stomach | 7 | 8.9** | 22 | 6.6 | * | # | 16 | 5.2** |
| Colon excluding Rectum | 33 | 48.3 | 138 | 42.8 | 11 | 17.3** | 66 | 20.2 |
| Rectum and Rectosigmoid Junction | 15 | 22.2** | 61 | 18.1 | 7 | 11.4** | 26 | 8.1 |
| Liver | * | # | 9 | 2.7** | * | # | 10 | 2.9** |
| Pancreas | 5 | 7.1** | 29 | 8.5 | * | # | 26 | 7.7 |
| Lung and Bronchus | 54 | 79.0 | 291 | 84.5 | 52 | 76.7 | 261 | 77.0 |
| Melanoma of the Skin | 23 | 32.3 | 55 | 15.9 | * | # | 12 | 3.4** |
| Prostate | 62 | 88.6 | 304 | 88.0 | 14 | 22.7** | 87 | 30.4 |
| Urinary Bladder | 15 | 23.9** | 93 | 28.6 | 6 | 10.0** | 26 | 8.8 |
| Kidney and Renal Pelvis | 12 | 15.1** | 51 | 13.9 | 5 | 6.9** | 22 | 6.3 |
| Brain and Other Nervous System | * | # | 29 | 7.3 | 5 | 6.2** | 20 | 5.4 |
| Non-Hodgkin Lymphoma | 13 | 18.4** | 74 | 20.3 | 5 | 8.5** | 43 | 12.8 |
| Myeloma | 5 | 7.4** | 19 | 5.7** | * | # | 15 | 5.0** |
| Leukemia | 10 | 14.6** | 49 | 14.0 | 8 | 12.2** | 36 | 11.2 |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2000 | 1996 - 2000 | 2000 | 1996 - 2000 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 340 | 373.0 | 1,662 | 374.4 | 157 | 167.7 | 715 | 156.0 |
| Colon excluding Rectum | 29 | 30.3 | 141 | 30.8 | 9 | 9.4** | 72 | 15.3 |
| Rectum and Rectosigmoid Junction | 10 | 10.9** | 53 | 11.7 | * | # | 13 | 2.7** |
| Liver | * | # | 4 | # | * | # | 5 | 1.1** |
| Pancreas | 9 | 9.4** | 28 | 6.2 | 11 | 11.1** | 29 | 6.2 |
| Lung and Bronchus | 41 | 46.4 | 190 | 43.3 | 29 | 32.2 | 156 | 34.8 |
| Melanoma of the Skin | 5 | 5.7** | 29 | 6.6 | * | # | 9 | 2.0** |
| Breast | 101 | 112.6 | 535 | 121.5 | 21 | 22.2 | 107 | 23.5 |
| Cervix Uteri | 5 | 5.6** | 31 | 7.1 | * | # | 14 | 3.2** |
| Corpus Uteri | 25 | 28.1 | 144 | 33.3 | * | # | 12 | 2.6** |
| Ovary | 13 | 14.4** | 69 | 15.6 | 6 | 6.7** | 34 | 7.4 |
| Urinary Bladder | 7 | 7.1** | 33 | 7.3 | * | # | 12 | 2.6** |
| Kidney and Renal Pelvis | 9 | 9.7** | 38 | 8.4 | * | # | 13 | 2.8** |
| Brain and Other Nervous System | 9 | 9.6** | 34 | 7.6 | * | # | 21 | 4.6 |
| Non-Hodgkin Lymphoma | 14 | 15.0** | 68 | 14.9 | 5 | 5.5** | 39 | 8.3 |
| Myeloma | * | # | 17 | 3.7** | 5 | 5.5** | 17 | 3.6** |
| Leukemia | 14 | 15.1** | 35 | 7.6 | 11 | 11.9** | 26 | 5.7 |
Rates are per 100,000; Age-adjusted, 2000 U.S. Standard Million.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, October 2004
Table of Contents
Table 5-19: Dubois
Table 5-21: Fayette
